# BriaCell Therapeutics Corp.: Form 8-K, filed Dec 8, 2022

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 8-K
- Filed: 2022-12-08
- Accepted by EDGAR: Dec 8, 2022, 09:25 ET
- Period: 2022-12-08
- Accession: 0001493152-22-034831
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315222034831/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315222034831/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315222034831/form8-k.htm

Filed Dec 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001493152-22-034831. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
